AA
Anthony Adamis
Director, CSO, EyeBio, a Merck Company · Stanford Health Care
Credentials: · ·
History
Ophthalmology
Research
Pegaptanib for neovascular age-related macular degeneration
New England Journal of Medicine · 2004 · 1,909 citations
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Review · Nature Reviews Drug Discovery · 2006 · Last of 6 authors · 1,146 citations
American Journal of Ophthalmology · 1994 · First of 7 authors · 1,090 citations
18 papers
- MT
14 papers · 11 as a resident
13 papers
- DG
11 papers
9 papers · 4 as a fellow
- EC
8 papers
8 papers · 5 as a resident
- BA
7 papers · 1 as a resident
Clinical trials
- 2007–2009
A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD
Study chair · Completed · Phase 1
Jerini Ophthalmic